SETH RUDNICK Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SETH RUDNICK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SETH RUDNICK. SETH RUDNICK is Director in POZEN INC /NC ($POZN) and Director in IMMUNICON CORP ($IMMC) and Director in Liquidia Technologies Inc ($LQDA) and Director in SQUARE 1 FINANCIAL INC ($SQBK) and in G1 Therapeutics, Inc. ($GTHX) and Director in G1 Therapeutics, Inc. ($GTHX) and Director in Aralez Pharmaceuticals Inc. ($ARLZ).
Latest Insider Trading Transactions of SETH RUDNICK
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GTHX, IMMC, LIQDA, ARLZ, POZN, SQBK
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 29 2020 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 20.10 | 924 | 18,572 | 5,266 | 6.2 K to 5.3 K (-14.93 %) | |
Dec 29 2020 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 20.10 | 924 | 18,572 | 5,266 | 6.2 K to 5.3 K (-14.93 %) | |
Dec 23 2020 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 20.18 | 13,118 | 264,757 | 6,190 | 19.3 K to 6.2 K (-67.94 %) | |
Dec 23 2020 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 20.33 | 18,974 | 385,702 | 19,308 | 38.3 K to 19.3 K (-49.56 %) | |
Dec 10 2020 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 20.00 | 546 | 10,921 | 38,282 | 38.8 K to 38.3 K (-1.41 %) | |
Dec 10 2020 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 20.32 | 5,773 | 117,284 | 38,828 | 44.6 K to 38.8 K (-12.94 %) | |
Dec 10 2020 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 20.19 | 13,161 | 265,694 | 44,601 | 57.8 K to 44.6 K (-22.78 %) | |
Dec 03 2020 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 20.09 | 520 | 10,449 | 57,762 | 58.3 K to 57.8 K (-0.89 %) | |
Jun 23 2020 | LIQDA | Liquidia Technolog ... | RUDNICK SETH | Director | Option Exercise | A | 10.97 | 20,000 | 219,400 | 20,000 | |
Jun 12 2020 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Director | Option Exercise | A | 17.59 | 20,000 | 351,800 | 20,000 | |
Sep 03 2019 | LQDA | Liquidia Technolog ... | RUDNICK SETH | Director | Option Exercise | A | 4.52 | 7,500 | 33,900 | 7,500 | |
Jun 14 2019 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Director | Option Exercise | A | 18.47 | 20,000 | 369,400 | 20,000 | |
Dec 04 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Option Exercise | M | 0.39 | 9,393 | 3,663 | 7,969 | ||
Dec 04 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Option Exercise | M | 0.39 | 607 | 237 | 0 | ||
Dec 04 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 40.00 | 116 | 4,640 | 0 | 116 to 0 (-100.00 %) | |
Dec 04 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 39.31 | 9,884 | 388,506 | 116 | 10 K to 116 (-98.84 %) | |
Dec 04 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Buy | M | 0.39 | 9,393 | 3,663 | 10,000 | 607 to 10 K (+1,547.45 %) | |
Dec 04 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Buy | M | 0.39 | 607 | 237 | 607 | 0 to 607 | |
Nov 07 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Option Exercise | M | 0.39 | 10,000 | 3,900 | 607 | ||
Nov 07 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 41.53 | 10,000 | 415,347 | 0 | 10 K to 0 (-100.00 %) | |
Nov 07 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Buy | M | 0.39 | 10,000 | 3,900 | 10,000 | 0 to 10 K | |
Oct 05 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Option Exercise | M | 0.39 | 10,000 | 3,900 | 10,607 | ||
Oct 05 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 49.99 | 1,980 | 98,981 | 0 | 2 K to 0 (-100.00 %) | |
Oct 05 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 49.65 | 8,020 | 398,229 | 1,980 | 10 K to 2 K (-80.20 %) | |
Oct 05 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Buy | M | 0.39 | 10,000 | 3,900 | 10,000 | 0 to 10 K | |
Sep 06 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Option Exercise | M | 0.39 | 10,000 | 3,900 | 20,607 | ||
Sep 06 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 60.31 | 500 | 30,155 | 0 | 500 to 0 (-100.00 %) | |
Sep 06 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 59.93 | 9,500 | 569,328 | 500 | 10 K to 500 (-95.00 %) | |
Sep 06 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Buy | M | 0.39 | 10,000 | 3,900 | 10,000 | 0 to 10 K | |
Aug 06 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Option Exercise | M | 0.39 | 10,000 | 3,900 | 30,607 | ||
Aug 06 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 50.69 | 10,000 | 506,901 | 0 | 10 K to 0 (-100.00 %) | |
Aug 06 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Buy | M | 0.39 | 10,000 | 3,900 | 10,000 | 0 to 10 K | |
Jun 11 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Director | Option Exercise | A | 38.39 | 10,000 | 383,900 | 10,000 | |
Jul 13 2017 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Director | Option Exercise | A | 15.55 | 20,000 | 311,000 | 20,000 | |
May 24 2017 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Director | Option Exercise | C | 0.00 | 8,271 | 0 | 0 | |
May 24 2017 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Director | Buy | C | 0.00 | 2,757 | 0 | 58,282 | 55.5 K to 58.3 K (+4.97 %) |
May 12 2017 | ARLZ | Aralez Pharmaceuti ... | RUDNICK SETH | Director | Option Exercise | A | 1.56 | 15,000 | 23,400 | 15,000 | |
May 12 2017 | ARLZ | Aralez Pharmaceuti ... | RUDNICK SETH | Director | Grant | A | 0.00 | 7,500 | 0 | 86,891 | 79.4 K to 86.9 K (+9.45 %) |
Dec 12 2016 | ARLZ | Aralez Pharmaceuti ... | RUDNICK SETH | Director | Gift | G | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
Dec 12 2016 | ARLZ | Aralez Pharmaceuti ... | RUDNICK SETH | Director | Gift | G | 0.00 | 30,000 | 0 | 64,391 | 94.4 K to 64.4 K (-31.78 %) |
Nov 15 2016 | ARLZ | Aralez Pharmaceuti ... | RUDNICK SETH | Director | Buy | P | 4.77 | 30,000 | 143,121 | 94,391 | 64.4 K to 94.4 K (+46.59 %) |
Jun 20 2016 | ARLZ | Aralez Pharmaceuti ... | RUDNICK SETH | Director | Option Exercise | A | 3.42 | 15,000 | 51,300 | 15,000 | |
Jun 20 2016 | ARLZ | Aralez Pharmaceuti ... | RUDNICK SETH | Director | Grant | A | 0.00 | 7,500 | 0 | 64,391 | 56.9 K to 64.4 K (+13.18 %) |
Feb 09 2016 | ARLZ | Aralez Pharmaceuti ... | RUDNICK SETH | Director | Buy | J | 0.00 | 47,501 | 0 | 47,501 | 0 to 47.5 K |
Oct 08 2015 | SQBK | SQUARE 1 FINANCIAL ... | RUDNICK SETH | Director | Option Exercise | D | 0.00 | 1,031 | 0 | 0 | |
Oct 08 2015 | SQBK | SQUARE 1 FINANCIAL ... | RUDNICK SETH | Director | Sell | D | 0.00 | 31,145 | 0 | 0 | 31.1 K to 0 (-100.00 %) |
Jun 25 2015 | POZN | POZEN INC /NC | RUDNICK SETH | Director | Option Exercise | M | 4.44 | 6,107 | 27,115 | 0 | |
Jun 25 2015 | POZN | POZEN INC /NC | RUDNICK SETH | Director | Option Exercise | M | 5.40 | 6,107 | 32,978 | 0 | |
Jun 25 2015 | POZN | POZEN INC /NC | RUDNICK SETH | Director | Option Exercise | M | 3.93 | 24,430 | 96,010 | 0 | |
Jun 25 2015 | POZN | POZEN INC /NC | RUDNICK SETH | Director | Option Exercise | M | 3.93 | 3,053 | 11,998 | 0 | |
Jun 25 2015 | POZN | POZEN INC /NC | RUDNICK SETH | Director | Payment of Exercise | F | 12.02 | 13,987 | 168,124 | 47,501 | 61.5 K to 47.5 K (-22.75 %) |
Jun 25 2015 | POZN | POZEN INC /NC | RUDNICK SETH | Director | Buy | M | 4.44 | 6,107 | 27,115 | 61,488 | 55.4 K to 61.5 K (+11.03 %) |
Jun 25 2015 | POZN | POZEN INC /NC | RUDNICK SETH | Director | Buy | M | 5.40 | 6,107 | 32,978 | 55,381 | 49.3 K to 55.4 K (+12.39 %) |
Jun 25 2015 | POZN | POZEN INC /NC | RUDNICK SETH | Director | Buy | M | 3.93 | 27,483 | 108,008 | 49,274 | 21.8 K to 49.3 K (+126.12 %) |
Jun 12 2015 | POZN | POZEN INC /NC | RUDNICK SETH | Director | Grant | A | 0.00 | 9,390 | 0 | 31,181 | 21.8 K to 31.2 K (+43.09 %) |
Feb 01 2005 | IMMC | IMMUNICON CORP | RUDNICK SETH | Director | Option Exercise | A | 6.12 | 10,000 | 61,200 | 10,000 | |
Apr 23 2004 | IMMC | IMMUNICON CORP | RUDNICK SETH | Director | Option Exercise | C | 0.00 | 10,250 | 0 | 0 | |
Apr 23 2004 | IMMC | IMMUNICON CORP | RUDNICK SETH | Director | Option Exercise | C | 0.00 | 6,329 | 0 | 0 | |
Apr 23 2004 | IMMC | IMMUNICON CORP | RUDNICK SETH | Director | Option Exercise | C | 0.00 | 93,225 | 0 | 0 | |
Apr 23 2004 | IMMC | IMMUNICON CORP | RUDNICK SETH | Director | Buy | C | 0.00 | 17,269 | 0 | 17,269 | 0 to 17.3 K |
Page: 1